What is LightDeck Diagnostics?
LightDeck Diagnostics, established in 2009 and headquartered in Boulder, Colorado, is a prominent player in the medtech industry, specializing in advanced pathogen diagnosis technology. The company's innovative solutions aim to revolutionize how infectious diseases are detected and managed, positioning it as a key contributor to public health advancements. Its strategic capital infusions are geared towards scaling operations and further developing its diagnostic platforms.
How much funding has LightDeck Diagnostics raised?
LightDeck Diagnostics has raised a total of $53.8M across 4 funding rounds:
Series A
$2M
Series B
$11M
Grant
$5.7M
Grant
$35.1M
Series A (2011): $2M, investors not publicly disclosed
Series B (2020): $11M led by Incubic, Entrada, and Boulder Ventures
Grant (2021): $5.7M supported by Biomedical Advanced Research and Development Authority
Grant (2021): $35.1M featuring U.S. Department of Defense
Key Investors in LightDeck Diagnostics
Boulder Ventures
Boulder Ventures Ltd. is a venture capital firm that specializes in investing in IT and biotech companies located in Colorado and the Mid-Atlantic region. The firm has a portfolio that includes 61 companies, with 28 successful exits and 10 initial public offerings (IPOs). Their focus is on supporting innovative businesses in the technology and biotechnology sectors. Boulder Ventures aims to foster growth and development in these industries through strategic investments.
U.S. Department of Defense
The U.S. Department of Defense, headquartered in the Pentagon in Arlington, Virginia, is the federal department responsible for coordinating and supervising all agencies and functions of the government directly related to national security and the United States Armed Forces. Founded in 1947, the Department operates globally with facilities across North America, Europe, Asia, and the Middle East. The Pentagon itself serves as the symbolic center of U.S. military operations and is one of the world's largest office buildings. The Department manages defense policy, military operations, and oversees the development and implementation of advanced security technologies and infrastructure to protect national interests. As a federal government entity, the Department of Defense provides various services including military defense, security operations, intelligence gathering, and emergency response capabilities.
Biomedical Advanced Research and Development Authority
The Biomedical Advanced Research and Development Authority (BARDA) is an office within the U.S. Department of Health and Human Services responsible for the development and procurement of medical countermeasures for public health emergencies. BARDA invests in research and development to address threats such as pandemic influenza, emerging infectious diseases, and chemical, biological, radiological, and nuclear (CBRN) threats. Their funding supports innovation across the spectrum of medical countermeasures, from early-stage research to late-stage development and manufacturing.
What's next for LightDeck Diagnostics?
With a recent major strategic investment and significant grant funding, LightDeck Diagnostics is poised for accelerated growth and technological development. The company's trajectory suggests a focus on expanding its market reach and enhancing its diagnostic capabilities. Future endeavors will likely involve further integration of its technologies into clinical settings and potentially new product launches, leveraging the recent capital to solidify its position in the competitive medtech landscape.
See full LightDeck Diagnostics company page
